Coloplast's new country-by-country tax report reveals enormous national differences

Denmark is in the lower end of the interval with a 20-percent effective tax rate, whereas the medtech company is paying nearly 40 percent of profits in France, the new details from Coloplast's country-by-country tax report show. The majority of its workforce reside in Hungary, where the lowest effective tax of 15 percent rate is also found. However, this is not why manufacturing has been established here, according to Coloplast.

The recently publicized country-by-country tax report reveals Coloplast's exact effective tax rates in individual EU member states | Photo: Coloplast / PR

There's a great deal of difference in how much of Coloplast's profit is taxed in individual countries, as evident in the Danish medtech firm's country-by-country tax report, which was released in connection with the company's full-year financial results.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs